Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NTSR1 | P30989 | 5/20 | 0.48 |
| ▸ | NTSR2 | O95665 | 4/20 | 0.48 |
| ▸ | SORT1 | Q99523 | 4/20 | 0.48 |
| ▸ | NPY2R | P49146 | 7/20 | 0.47 |
| ▸ | NPY4R | P50391 | 7/20 | 0.47 |
| ▸ | NPY5R | Q15761 | 7/20 | 0.47 |
| ▸ | NPY1R | P25929 | 5/20 | 0.47 |
| ▸ | KDM1A | O60341 | 2/20 | 0.46 |
| ▸ | GRB2 | P62993 | 1/20 | 0.46 |
| ▸ | CALCRL | Q16602 | 1/20 | 0.45 |
| ▸ | CAPN1 | P07384 | 2/20 | 0.45 |
| ▸ | CTSD | P07339 | 1/20 | 0.44 |
| ▸ | BACE1 | P56817 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL32677422 | 1.00 | NTSR1 (0.48) | NTSR1NTSR2SORT1NPY2RNPY4R | |
| SCHEMBL30166936 | 0.92 | NPY2R (0.50) | NTSR1NTSR2SORT1NPY2RNPY4R | |
| SCHEMBL29933803 | 0.90 | GRB2 (0.48) | NTSR1NTSR2SORT1NPY2RNPY4R | |
| SCHEMBL30422906 | 0.89 | GRB2 (0.51) | NTSR1NTSR2SORT1GRB2CAPN1 | |
| SCHEMBL30311198 | 0.89 | GRB2 (0.49) | NTSR1NTSR2SORT1NPY2RNPY4R | |
| SCHEMBL23639489 | 0.88 | NTSR1 (0.53) | NTSR1NTSR2SORT1CAPN1 | |
| SCHEMBL29639697 | 0.88 | RAMP3 (0.49) | NPY2RNPY4RNPY5RNPY1RKDM1A | |
| SCHEMBL31182748 | 0.86 | KDM1A (0.49) | NTSR1NTSR2SORT1NPY2RNPY4R | |
| SCHEMBL30401020 | 0.85 | KDM1A (0.50) | NTSR1NTSR2SORT1NPY2RNPY4R | |
| SCHEMBL29462921 | 0.85 | GRB2 (0.51) | NTSR1NTSR2SORT1GRB2CAPN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260055137-A1 | NOVEL ISOLATED PEPTIDES, PROTEIN HYDROLYSATE COMPRISING THE SAID ISOLATED PEPTIDES AND USE THEREOF | BETAGRO PUBLIC COMPANY LIMITED (TH) | 2026-02-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260055137-A1 | NOVEL ISOLATED PEPTIDES, PROTEIN HYDROLYSATE COMPRISING THE SAID ISOLATED PEPTIDES AND USE THEREOF | VIP, ARGLU1, PELP1 | NTSR1 838/4885NTSR2 872/4885SORT1 2799/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.